# Aqua Metals, Inc.: financial statements, quarterly

AQMS · Nasdaq · CIK 1621832 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/aqms.md) · [Financials](/companies/aqms/financials.md) · [Filings](/companies/aqms/filings.md) · [Insiders](/companies/aqms/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/aqms/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [0.0](/filings/0001437749-24-035288.md) | [0.0 d](/filings/0001437749-25-010177.md) | [0.0](/filings/0001437749-25-015480.md) | [0.0 d](/filings/0001437749-25-026499.md) | [0.0](/filings/0001437749-24-035288.md) | [0.0 d](/filings/0001437749-25-010177.md) | [0.0](/filings/0001437749-25-026499.md) | not reported | not reported | not reported | not reported | not reported |
| Cost of revenue | $m | [1.8](/filings/0001437749-24-035288.md) | [2.0 d](/filings/0001437749-25-010177.md) | [2.2](/filings/0001437749-25-015480.md) | [2.4](/filings/0001437749-25-026499.md) | [1.6](/filings/0001437749-25-034439.md) | [1.0 d](/filings/0001437749-26-010705.md) | [0.7](/filings/0001437749-26-017038.md) | [0.8](/filings/0001437749-26-025091.md) | [0.6](/filings/0001437749-25-034439.md) | [0.3 d](/filings/0001437749-26-010705.md) | [0.5](/filings/0001437749-26-017038.md) | [0.6](/filings/0001437749-26-025091.md) |
| Research and development | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [(4.9)](/filings/0001437749-24-035288.md) | [(10.2) d](/filings/0001437749-25-010177.md) | [(5.8)](/filings/0001437749-25-015480.md) | [(6.2)](/filings/0001437749-25-026499.md) | [(5.2)](/filings/0001437749-25-034439.md) | [(6.7) d](/filings/0001437749-26-010705.md) | [(8.7)](/filings/0001437749-26-017038.md) | [(7.0)](/filings/0001437749-26-025091.md) | [(3.1)](/filings/0001437749-25-034439.md) | [(4.6) d](/filings/0001437749-26-010705.md) | [(4.1)](/filings/0001437749-26-017038.md) | [(4.6)](/filings/0001437749-26-025091.md) |
| Interest expense | $m | [0.1](/filings/0001437749-23-030935.md) | [0.1 d](/filings/0001437749-24-009870.md) | [0.1](/filings/0001437749-24-017078.md) | [0.1](/filings/0001437749-25-026499.md) | [0.1](/filings/0001437749-25-034439.md) | [0.3 d](/filings/0001437749-26-010705.md) | [0.4](/filings/0001437749-26-017038.md) | [0.2](/filings/0001437749-26-025091.md) | [0.0](/filings/0001437749-25-034439.md) | [0.0 d](/filings/0001437749-26-010705.md) | [0.0](/filings/0001437749-26-017038.md) | [0.0](/filings/0001437749-26-025091.md) |
| Income tax | $m | [0.0](/filings/0001437749-24-035288.md) | [0.0 d](/filings/0001437749-25-010177.md) | not reported | [0.0](/filings/0001437749-24-026781.md) | [0.0](/filings/0001437749-24-035288.md) | [0.0 d](/filings/0001437749-26-010705.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $m | [(4.5)](/filings/0001437749-24-035288.md) | [(10.0) d](/filings/0001437749-25-010177.md) | [(5.8)](/filings/0001437749-25-015480.md) | [(6.2)](/filings/0001437749-25-026499.md) | [(5.2)](/filings/0001437749-25-034439.md) | [(7.4) d](/filings/0001437749-26-010705.md) | [(8.3)](/filings/0001437749-26-017038.md) | [(6.8)](/filings/0001437749-26-025091.md) | [(3.1)](/filings/0001437749-25-034439.md) | [(4.4) d](/filings/0001437749-26-010705.md) | [(4.0)](/filings/0001437749-26-017038.md) | [(4.5)](/filings/0001437749-26-025091.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Basic EPS | $ per share | [(0.89)](/filings/0001437749-24-035288.md) | not reported | [(1.05)](/filings/0001437749-25-015480.md) | [(9.94)](/filings/0001437749-25-026499.md) | [(7.64)](/filings/0001437749-25-034439.md) | not reported | [(10.27)](/filings/0001437749-26-017038.md) | [(7.44)](/filings/0001437749-26-025091.md) | [(2.19)](/filings/0001437749-25-034439.md) | not reported | [(1.22)](/filings/0001437749-26-017038.md) | [(1.31)](/filings/0001437749-26-025091.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Research and development: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: not reported
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [25.6](/filings/0001437749-23-030935.md) | [16.5](/filings/0001437749-25-010177.md) | [8.3](/filings/0001437749-24-017078.md) | [7.8](/filings/0001437749-24-026781.md) | [3.0](/filings/0001437749-24-035288.md) | [4.1](/filings/0001437749-26-010705.md) | [1.6](/filings/0001437749-25-015480.md) | [1.9](/filings/0001437749-25-026499.md) | [3.6](/filings/0001437749-25-034439.md) | [10.8](/filings/0001437749-26-025091.md) | [6.8](/filings/0001437749-26-017038.md) | [4.7](/filings/0001437749-26-025091.md) |
| Current assets | $m | [26.7](/filings/0001437749-23-030935.md) | [18.3](/filings/0001437749-25-010177.md) | [10.1](/filings/0001437749-24-017078.md) | [9.3](/filings/0001437749-24-026781.md) | [4.2](/filings/0001437749-24-035288.md) | [4.6](/filings/0001437749-26-010705.md) | [2.2](/filings/0001437749-25-015480.md) | [2.4](/filings/0001437749-25-026499.md) | [4.0](/filings/0001437749-25-034439.md) | [13.4](/filings/0001437749-26-025091.md) | [11.1](/filings/0001437749-26-017038.md) | [6.9](/filings/0001437749-26-025091.md) |
| Total assets | $m | [42.0](/filings/0001437749-23-030935.md) | [33.6](/filings/0001437749-25-010177.md) | [31.4](/filings/0001437749-24-017078.md) | [33.7](/filings/0001437749-24-026781.md) | [28.5](/filings/0001437749-24-035288.md) | [26.4](/filings/0001437749-26-010705.md) | [18.1](/filings/0001437749-25-015480.md) | [9.2](/filings/0001437749-25-026499.md) | [10.5](/filings/0001437749-25-034439.md) | [19.7](/filings/0001437749-26-025091.md) | [17.1](/filings/0001437749-26-017038.md) | [12.6](/filings/0001437749-26-025091.md) |
| Current liabilities | $m | [3.6](/filings/0001437749-23-030935.md) | [4.6](/filings/0001437749-25-010177.md) | [8.5](/filings/0001437749-24-017078.md) | [7.9](/filings/0001437749-24-026781.md) | [7.1](/filings/0001437749-24-035288.md) | [8.2](/filings/0001437749-26-010705.md) | [7.2](/filings/0001437749-25-015480.md) | [3.6](/filings/0001437749-25-026499.md) | [3.5](/filings/0001437749-25-034439.md) | [4.4](/filings/0001437749-26-025091.md) | [3.6](/filings/0001437749-26-017038.md) | [2.8](/filings/0001437749-26-025091.md) |
| Total liabilities | $m | [6.5](/filings/0001437749-23-030935.md) | [7.5](/filings/0001437749-25-010177.md) | [8.6](/filings/0001437749-24-017078.md) | [8.4](/filings/0001437749-24-026781.md) | [7.6](/filings/0001437749-24-035288.md) | [10.1](/filings/0001437749-26-010705.md) | [8.5](/filings/0001437749-25-015480.md) | [4.1](/filings/0001437749-25-026499.md) | [4.0](/filings/0001437749-25-034439.md) | [4.9](/filings/0001437749-26-025091.md) | [4.0](/filings/0001437749-26-017038.md) | [3.1](/filings/0001437749-26-025091.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [35.4](/filings/0001437749-24-035288.md) | [26.1](/filings/0001437749-26-010705.md) | [22.9](/filings/0001437749-25-026499.md) | [25.2](/filings/0001437749-25-034439.md) | [20.9](/filings/0001437749-25-034439.md) | [16.2](/filings/0001437749-26-025091.md) | [9.5](/filings/0001437749-26-025091.md) | [5.1](/filings/0001437749-26-025091.md) | [6.5](/filings/0001437749-25-034439.md) | [14.8](/filings/0001437749-26-025091.md) | [13.1](/filings/0001437749-26-025091.md) | [9.5](/filings/0001437749-26-025091.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(3,250) d](/filings/0001437749-24-035288.md) | [(5,415) d](/filings/0001437749-25-010177.md) | [(4,251)](/filings/0001437749-25-015480.md) | [(3,751) d](/filings/0001437749-25-026499.md) | [(3,635) d](/filings/0001437749-25-034439.md) | [(1,995) d](/filings/0001437749-26-010705.md) | [(2,753)](/filings/0001437749-26-017038.md) | [(2,546) d](/filings/0001437749-26-025091.md) | [(2,349) d](/filings/0001437749-25-034439.md) | [(2,605) d](/filings/0001437749-26-010705.md) | [(3,844)](/filings/0001437749-26-017038.md) | [(2,630) d](/filings/0001437749-26-025091.md) |
| Capital expenditure | $k | [639 d](/filings/0001437749-24-035288.md) | [(544) d](/filings/0001437749-25-010177.md) | [2,737](/filings/0001437749-25-015480.md) | [3,703 d](/filings/0001437749-25-026499.md) | [1,012 d](/filings/0001437749-25-034439.md) | [469 d](/filings/0001437749-26-010705.md) | [289](/filings/0001437749-26-017038.md) | [132 d](/filings/0001437749-26-025091.md) | [0.0 d](/filings/0001437749-25-034439.md) | [4.0 d](/filings/0001437749-26-010705.md) | [0.0](/filings/0001437749-26-017038.md) | [0.0 d](/filings/0001437749-26-025091.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

Shares outstanding: 3,563,531 at 2026-07-24, from the cover of the [10-Q filed 2026-07-30](/filings/0001437749-26-025091.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:44 ET. No prices; not investment advice.